How sickle cell anemia led the quest to edit the human genome while patients endured decades of racial discrimination and medical neglect.
In December 1904, Walter Clement Noel, a dental student from Grenada, was admitted to a Chicago hospital with fever, jaundiced eyes, and leg ulcers. When doctors examined his blood under a microscope, they were puzzled by his sickle-shaped cells. His case became enshrined in the annals of medicine as the first report of sickle cell anemia, a life-threatening disease that starves the body’s organs of oxygen, causing excruciating pain.
In Curved Air, Kevin Davies chronicles the story of sickle cell anemia from its ancient origins in Sub-Saharan Africa to its surprising role in the success of human genome editing, revealing how one of the world’s most famous genetic diseases was also among its most neglected. Scientists discovered the molecular anomaly responsible for the disease over 75 years ago. Yet for decades, patients, many of them Black, suffered in silence, denied urgent care by a healthcare system quick to dismiss them as drug seekers. It was only in 2023, after researchers in the US and Europe partnered with biotech companies, that hope arrived in the approval of a revolutionary gene editing therapy: CRISPR.
Giving voice to the sickle cell pioneers, including Victoria Gray, who bravely became the first volunteer to have her blood cells engineered, Curved Air is at once a story of failure and breakthroughs, heartbreak and hope. It is also a celebration of the scientists, physicians, and, above all, the patients who are finally catching a glimpse of the cure they have waited generations to see.
Born and raised in London, Kevin Davies studied at Oxford University and moved to the U.S. in 1987 after earning his PhD in genetics. He endured two years at the bench before seeking refuge in the editorial office of Nature magazine. He was the founding editor of the journal Nature Genetics and has also worked at Cell Press and the Howard Hughes Medical Institute. He is currently the editor of Bio-IT World magazine, based in Boston.
The $1,000 Genome is Kevin's third book, and second for the Free Press. He published Cracking the Genome, about the race for the Human Genome Project, in 2000. His first book, Breakthrough, co-authored with Michael White, was about the race to identify the "breast cancer gene" in the mid-'90s.
Absolutely fascinating yet also horrifying as we learn that yet again, access to e ffective, affordable, and compassionate medical care to Americans of color is broken.
I learned a lot about Sickle Cell Disease from this book. I didn't know about all the discrimination that sufferers had to deal with. I am an organic chemist, but I have no medical or biology training, so many of the medical and biological details went over my head. I found one error (in the hardcover edition): On page 131, the formula for hydroxyurea is terribly incorrect: it should be CH4N2O2, NOT N2H2O4!!!